1Kelly CP, Pothoulakis C, LaMont JT, et al. Current Concepts:Clostridium difficile colitis.New Eng J Med, 1994,330: 257-263.
2Mcfarland LV. Epidemiology, risk factors and treatment for antibiotic-associated diarrhea. Dig Dis, 1998, 16 :292-307.
3DonnConnor,Pearl Hynes,Martin Cormican,et al.Evaluation of Methods for Detection of Toxins in Speciments of Feces Submitted for Diagnosis of Clostridium difficile-Associated Diarrhea[J].Clinil Microbioly,2001,39(8):2846-2849.
6Barbut E.Kajzer Planas N.et al.Comparison of three enzyme immunoassays,a cytotoxicity assay,and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea[J].Clin Microbiol,1993,31:963-967.
7Fekety R,Shah AB.Diagnosis and treatment of Clostridium difficile colitis[J].JAMA,1993,269:71-75.
8Wenisch C,Parschalk B,Hasenhundl M,et al.Comparison of vancomycin,tejcoplanin,metronidazole,and fusidic acid for the treatment of Clostridium difficile-associated diarrhea[J].Clin Infect Dis,1996,22:813-818.
9Kyne L,Warny M,Qamar A,et al.Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea[J].Lancet,2001,357:189-193.
10Salcedo J,Keates S,Pothoulakis C,et al.Intravenous immunoglobulin therapy for severe Clostridium difficile colitis[J].Gut,1997,41:366-370.
